{"id":51632,"date":"2022-12-06T18:02:27","date_gmt":"2022-12-06T17:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/"},"modified":"2022-12-06T18:02:27","modified_gmt":"2022-12-06T17:02:27","slug":"millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/","title":{"rendered":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of Ethide Laboratories (\u201cEthide Labs\u201d or \u201cEthide\u201d), on November 14, 2022.\n<\/p>\n

\nHeadquartered in West Warwick, Rhode Island, Ethide Labs has more than 60 years of experience in regulatory testing services for the medical device and pharmaceutical industries. Ethide Labs is an ISO 13485:2016 certified testing laboratory with capabilities in ethylene oxide (EO) residual, microbiology, bioburden, sterility, and package integrity testing and environmental monitoring services. With a technical staff of degreed scientists who are active members of the American Society for Microbiology, an FDA-compliant facility, and adherence to the most rigorous national and international standards, Ethide Labs is aligned with Millstone\u2019s commitment to operating under the highest quality standards. Bringing Ethide Labs into the Millstone family of companies enhances its full range of specialty precision testing services. The acquisition will also further strengthen Millstone\u2019s Tier 1 end-to-end expert sourcing and support services.\n<\/p>\n

\nMatt Altman, a Managing Partner at Arlington Capital Partners, said, \u201cThe strategic acquisition of Ethide Laboratories expands Millstone\u2019s testing capabilities and broadens its customer footprint. We are excited by the wide range of growth opportunities that will be created from bringing these companies together.\u201d\n<\/p>\n

\n\u201cWe are excited to bring Ethide Labs into the Millstone family of companies,\u201d Millstone Medical Outsourcing CEO Karl Neuberger said. \u201cMillstone is dedicated to helping our customers focus on the products that change patients\u2019 lives through best-in-class post-manufacturing services that ensure quality, compliance, and business success. With the specialty testing expertise and proven success of Ethide Labs, we continue to expand the end-to-end support we offer in-house\u2014with the quality and expertise our customers have come to rely on.\u201d\n<\/p>\n

\nThe Ethide Labs leadership team will join Millstone\u2019s experts. Regarding the acquisition, Ethide Labs CEO Sarath Koruprolu said, \u201cFor 60 years, Ethide Labs has supported the medical device market and related industries with expert guidance and accelerated turnaround times so our customers can focus on bringing products to market faster. We are thrilled to join forces with Millstone and to bring our expertise together with theirs to deliver life-changing and lifesaving products.\u201d\n<\/p>\n

\nGordon Auduong, a Principal at Arlington Capital Partners, added, \u201cWe were highly impressed with Ethide\u2019s broad set of testing capabilities as well as its firm commitment to the highest quality standards. Alongside Millstone\u2019s acquisition of MycoScience earlier this month, the acquisition of Ethide demonstrates Millstone\u2019s success in adding testing services to its pre-existing broad range of services.\u201d\n<\/p>\n

\nAbout Millstone Medical Outsourcing<\/b>\n<\/p>\n

\nMillstone Medical Outsourcing is a leading provider of customized outsourcing solutions to the medical device industry with a client roster of the most prominent global OEMs as well as emerging growth companies. Millstone delivers superior quality service, unparalleled expertise, and guaranteed ROI. The company offers advanced inspection, sterile and non-sterile packaging, loaner kit processing, and distribution services to device and product manufacturers worldwide. Millstone is privately held and operates state-of-the-art facilities in Fall River, MA, and Olive Branch, MS. The company is FDA registered and ISO certified by BSI, Inc. to ISO 13485: 2016.\n<\/p>\n

\nFor more information: www.millstonemedical.com<\/a>\n<\/p>\n

\nAbout Arlington Capital Partners<\/b>\n<\/p>\n

\nArlington Capital Partners is a Washington, DC-based private equity firm that has managed approximately $7 billion in capital commitments. Arlington is focused on middle market investment opportunities in growth industries including healthcare, government services and technology, aerospace & defense, and business services and software. The firm\u2019s professionals and network have a unique combination of operating and private equity experience that enable Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and\/or advance their company\u2019s position as leading competitors in their field.\n<\/p>\n

\nFor more information: www.arlingtoncap.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Altman & Gordon Auduong
\n
Arlington Capital Partners
\n
5425 Wisconsin Avenue, Suite 200
\n
Chevy Chase, MD 20815
\n
(202) 337-7500\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of Ethide Laboratories (\u201cEthide Labs\u201d or \u201cEthide\u201d), on November 14, 2022. Headquartered in West Warwick, Rhode Island, Ethide Labs has more than 60 years of experience in regulatory testing services for the medical … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51632","6":"format-standard","7":"category-industry"},"yoast_head":"\nMillstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of Ethide Laboratories (\u201cEthide Labs\u201d or \u201cEthide\u201d), on November 14, 2022. Headquartered in West Warwick, Rhode Island, Ethide Labs has more than 60 years of experience in regulatory testing services for the medical ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-06T17:02:27+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories\",\"datePublished\":\"2022-12-06T17:02:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/\"},\"wordCount\":655,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/\",\"name\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-12-06T17:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/","og_locale":"en_US","og_type":"article","og_title":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of Ethide Laboratories (\u201cEthide Labs\u201d or \u201cEthide\u201d), on November 14, 2022. Headquartered in West Warwick, Rhode Island, Ethide Labs has more than 60 years of experience in regulatory testing services for the medical ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-06T17:02:27+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories","datePublished":"2022-12-06T17:02:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/"},"wordCount":655,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/","url":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/","name":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-12-06T17:02:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-ethide-laboratories\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51632"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51632\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}